Tourmaline Bio
Aaron Kantoff is a seasoned entrepreneur and leader in the biotechnology sector, currently serving as Co-Founder and Managing Partner at Scion Life Sciences since January 2022, and as a Board Member at Tourmaline Bio since April 2022, focusing on innovative treatments for immune and inflammatory diseases. Kantoff has held key board positions at various organizations, including RayzeBio, Centessa Pharmaceuticals, Akero Therapeutics, Corvidia Therapeutics, and Elstar Therapeutics, contributing to the development of transformative therapies within the fields of metabolic disease and cardiovascular health. With a wealth of experience in venture capital as a Partner at Apple Tree Partners, Kantoff possesses strong expertise in building and investing in biotech companies. Educationally, Kantoff holds a Bachelor of Science in Finance and International Business from New York University - Leonard N. Stern School of Business.
This person is not in the org chart
This person is not in any teams
Tourmaline Bio
2 followers
Tourmaline is a late-stage clinical biotechnology company driven by our mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune and inflammatory diseases. In doing so, we seek to develop assets medicines that have the potential to establish new standards-of-care in areas of high unmet medical need.